Marcel Luyten

Title: Marcel Luyten: Innovator in Transgenic Research

Introduction

Marcel Luyten is a notable inventor based in Arisdorf, Switzerland. He has made significant contributions to the field of genetic research, particularly in the development of transgenic animals. His work focuses on understanding gene regulation and its implications in various biological processes.

Latest Patents

Luyten holds a patent for "Transgenic animals for studying regulation of genes." This patent describes a transgenic non-human animal, such as a transgenic mouse, that comprises a polynucleotide encoding a soluble marker protein functionally linked to a regulatory sequence of an endogenous gene encoding E-selectin. The patent also outlines methods for detecting modulators of the E-selectin gene using the transgenic non-human animal and cultured cells derived from it. He has 1 patent to his name.

Career Highlights

Marcel Luyten is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to engage in cutting-edge research and development in the field of genetics and biotechnology. His innovative work has the potential to advance our understanding of gene regulation and its applications in medicine.

Collaborations

Throughout his career, Luyten has collaborated with esteemed colleagues, including Edgar Käslin and Hans-Günter Zerwes. These collaborations have contributed to the advancement of research in transgenic technology and gene regulation.

Conclusion

Marcel Luyten's contributions to the field of genetic research through his innovative patent and work at Novartis AG highlight his role as a key figure in advancing our understanding of gene regulation. His research continues to pave the way for future discoveries in biotechnology.